CORTESE, ROSA
 Distribuzione geografica
Continente #
EU - Europa 1.935
AS - Asia 1.336
NA - Nord America 1.322
SA - Sud America 376
AF - Africa 29
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.001
Nazione #
US - Stati Uniti d'America 1.289
SG - Singapore 508
RU - Federazione Russa 503
IT - Italia 493
CN - Cina 333
BR - Brasile 327
IE - Irlanda 323
HK - Hong Kong 150
GB - Regno Unito 135
SE - Svezia 119
VN - Vietnam 95
KR - Corea 92
FR - Francia 77
DE - Germania 75
FI - Finlandia 57
ES - Italia 54
IN - India 50
NL - Olanda 33
CA - Canada 16
BD - Bangladesh 15
TR - Turchia 15
AR - Argentina 14
IR - Iran 14
PL - Polonia 13
ID - Indonesia 12
AT - Austria 11
ZA - Sudafrica 11
IQ - Iraq 10
UA - Ucraina 10
MX - Messico 9
CH - Svizzera 8
CL - Cile 7
CO - Colombia 7
EC - Ecuador 7
JP - Giappone 7
HU - Ungheria 6
PK - Pakistan 6
BE - Belgio 5
CI - Costa d'Avorio 5
PY - Paraguay 5
SA - Arabia Saudita 5
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
PE - Perù 4
UZ - Uzbekistan 4
VE - Venezuela 4
AL - Albania 3
MN - Mongolia 3
TN - Tunisia 3
AU - Australia 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
OM - Oman 2
PH - Filippine 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 5.001
Città #
Dallas 325
Dublin 299
Singapore 269
Santa Clara 220
Hong Kong 147
Moscow 135
Hefei 122
Ashburn 98
Southend 95
Seoul 92
Siena 84
Beijing 83
Milan 63
Chandler 49
Los Angeles 45
Málaga 44
Ho Chi Minh City 33
Helsinki 31
Munich 31
Princeton 31
São Paulo 29
Rome 27
Fairfield 23
Florence 23
Bengaluru 21
Buffalo 18
New York 17
Hanoi 16
Pisa 16
Lappeenranta 15
Redondo Beach 14
Cambridge 13
Nuremberg 13
San Francisco 13
Boston 12
Houston 12
Sarzana 12
Seattle 12
Belo Horizonte 11
Chicago 11
Wilmington 11
Livorno 10
Lucca 10
Salvador 10
Woodbridge 10
London 9
Phoenix 9
Reggio Emilia 9
Rio de Janeiro 9
Warsaw 9
Carlentini 8
Fremont 8
Montreal 8
Naples 8
Turin 8
Turku 8
Chennai 7
Dong Ket 7
Porto Alegre 7
Tokyo 7
Amsterdam 6
Baghdad 6
Bari 6
Boardman 6
Brooklyn 6
Campinas 6
Frankfurt am Main 6
Orem 6
Sacramento 6
Shanghai 6
Tehran 6
Abidjan 5
Atlanta 5
Brasília 5
Brussels 5
Council Bluffs 5
Falkenstein 5
Gyomro 5
Hải Dương 5
Mexico City 5
Monsummano Terme 5
San Diego 5
Vicopisano 5
Americana 4
Amman 4
Columbus 4
Denver 4
Des Moines 4
Dhaka 4
Haiphong 4
Jacksonville 4
Johannesburg 4
Manchester 4
Messina 4
Nairobi 4
New Delhi 4
Pescara 4
Pistoia 4
Salt Lake City 4
São José do Rio Preto 4
Totale 2.990
Nome #
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 267
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 171
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 169
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 165
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 152
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 134
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 122
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 117
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 114
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging 107
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years 106
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy 106
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis 105
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique 104
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 102
Uveitis: A snapshot in the MOG antibody spectrum 102
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 102
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 101
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 100
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 100
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 98
Gender Inequities in the Multiple Sclerosis Community: A Call for Action 97
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD 96
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation 95
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 95
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis 92
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio 92
Editorial: Cognition in Multiple Sclerosis 91
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 90
Advances in brain imaging in multiple sclerosis 90
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique 89
Fatigue in multiple sclerosis: The role of thalamus 87
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging – Yes 87
Vessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation 85
Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (npj Digital Medicine, (2019), 2, 1, (49), 10.1038/s41746-019-0127-8) 85
Evaluation of cervical spinal cord atrophy using a modified SIENA approach 84
High-dimensional detection of imaging response to treatment in multiple sclerosis 84
Magnetic resonance imaging evidence supporting the efficacy of cladribine tablets in the treatment of relapsing-remitting multiple sclerosis 82
Structural and functional connectivity substrates of cognitive impairment in multiple sclerosis 81
MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease 80
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis 79
Primary progressive multiple sclerosis presenting under the age of 18 years: Fact or fiction? 78
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis 78
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study 72
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know? 71
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 71
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression 66
Amyotrophic lateral sclerosis: A new missense mutation in the SOD1 gene 56
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 54
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 50
The role of imaging in Hirayama disease 27
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 25
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 24
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 24
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP) 24
Hirayama disease: the importance of an early diagnosis 22
Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal 21
Totale 5.168
Categoria #
all - tutte 21.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 6 3 11 10 12 7 9
2021/2022227 4 1 3 2 3 6 2 1 83 9 52 61
2022/2023528 25 36 78 47 20 86 71 41 47 46 14 17
2023/2024453 12 14 37 18 10 109 175 13 6 12 5 42
2024/20251.653 47 67 145 95 211 83 83 107 145 95 171 404
2025/20262.131 303 460 352 410 549 57 0 0 0 0 0 0
Totale 5.168